Pharmaceutical Promotion in Bangladesh: Assessing the Strength of Regulatory Documents

Authors

Keywords:

Ethical pharmaceutical promotion, Code of Pharmaceutical Marketing Practices, Drug Policy, Laws, Regulation of promotion, Bangladesh situation

Abstract

Pharmaceutical promotion is a negative influencing force for prescribing. However, very few regulatory initiatives are taken to overcome this unwarranted influence. The present research was conducted in such context with an attempt to review the regulatory documents related to pharmaceutical promotion in Bangladesh including Code of Pharmaceutical Marketing Practices (CPMP), and to compare CPMP with different global guidelines. The studied guidelines demonstrate effort to regulate promotion, though that varies to a great extent, particularly in enforcement aspects. Clearly defined ethical and legal prohibitions, provisions of punishment for violations and entrusted agency with defined authority are crucial.

Downloads

Download data is not yet available.
Abstract
1
PDF
5

Author Biographies

Fatema Johora, Assistant Professor, Department of PharmacologyArmy Medical College Bogura, Bogura Cantonment,

 Bangladesh

Md Sayedur Rahman, Professor, Department of Pharmacology, Bangabandhu Sheikh Mujib Medical University, Dhaka,

Bangladesh.

Downloads

Published

2018-11-04

How to Cite

Johora, F., & Rahman, M. S. (2018). Pharmaceutical Promotion in Bangladesh: Assessing the Strength of Regulatory Documents. Bangladesh Journal of Bioethics, 9(3), 1–10. Retrieved from https://banglajol.info/index.php/BIOETHICS/article/view/48911

Issue

Vol. 9 No. 3 (2018)

Section

Articles

License

(c) Bangladesh Journal of Bioethics.  

Creative Commons Licence
Articles in the Bangladesh Journal of Bioethics are Open Access articles published under the Creative Commons CC BY-NC-ND License Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. This license permits use, distribution and reproduction in any medium, provided the original work is properly cited, is not changed in any way, and is not used for commercial purposes.